Management of pulmonary hypertension associated with valvular heart disease with angiotensin‐receptor neprilysin inhibitor

Pulmonary hypertension secondary to left‐sided valvular disease (VHD‐PH) is associated with high morbidity and mortality. Angiotensin‐receptor neprilysin inhibitor (ARNI) is a novel pharmacotherapy, which reduces afterload with natriuresis and peripheral vasodilation. Our cases demonstrate that ARNI...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Hyeon‐Ju Ryoo, Thomas, Jerome, Sahay, Sandeep, Guha, Ashrith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626127/
https://www.ncbi.nlm.nih.gov/pubmed/37937122
http://dx.doi.org/10.1002/pul2.12303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626127/
https://www.ncbi.nlm.nih.gov/pubmed/37937122
http://dx.doi.org/10.1002/pul2.12303

Ejemplares similares